Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 24,917	$ 27,273
Trade and other receivables, net	8,550	4,704
Inventories, net	7,079	5,780
Prepaid expenses and other current assets	1,911	2,131
Total current assets	42,457	39,888
Property and equipment, net	4,551	4,085
Right-of-use assets, net	5,669	5,211
Intangible assets, net	1,317	1,435
Other non-current assets	5,454	6,451
Total assets	59,448	57,070
Current liabilities:
Accounts payable	9,994	9,946
Accrued expenses	5,468	7,967
Lease liabilities, current	367	255
Deferred revenue, current	2,637	1,513
Liability related to the sale of future revenue, current	985	1,147
Loans payable, current	4,606	18,700
Total current liabilities	24,057	39,528
Loans payable, net	34,555	33,448
Liability related to the sale of future revenue, net	63,511	64,112
Lease liabilities	5,509	5,085
Deferred revenue	32,732	31,417
Other non-current liabilities	2,011	2,034
Total liabilities	162,375	175,624
Contingencies (Note 19)
Stockholders’ deficit:
Common stock, $0.001 par value. Authorized 250,000,000 shares; 66,740,765 and 54,827,734 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	67	55
Additional paid-in capital	207,972	192,598
Accumulated deficit	(310,966)	(311,207)
Total stockholders’ deficit	(102,927)	(118,554)
Total liabilities and stockholders’ deficit	$ 59,448	$ 57,070
Common stock, shares outstanding (in shares)	66,740,765	54,827,734
Common stock, shares issued (in shares)	66,740,765	54,827,734